Clinical Trials on Recurrent Ureter Urothelial Carcinoma in Korea, Democratic People's Republic of
Total 101 results
-
Seoul National University HospitalUnknownUrothelial CarcinomaKorea, Republic of
-
Asan Medical CenterKorean Cancer Study GroupUnknownTransitional Cell Carcinoma | Bladder Cancer | Ureter Cancer | Urethral CancerKorea, Republic of
-
National Cancer Center, KoreaSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Korea University Anam Hospital and other collaboratorsRecruitingUrothelial CarcinomaKorea, Republic of
-
Asan Medical CenterUnknownAdvanced Urothelial CarcinomaKorea, Republic of
-
Yonsei UniversityRecruitingProstate Cancer | Bladder Cancer | Renal Cell Cancer | Ureter CancerKorea, Republic of
-
Asan Medical CenterCompletedUrothelial CarcinomaKorea, Republic of
-
Samsung Medical CenterActive, not recruitingUrothelial CarcinomaKorea, Republic of
-
Yonsei UniversityRecruitingProstate Cancer | Bladder Cancer | Renal Cell Cancer | Ureter Cancer | Urological MalignanciesKorea, Republic of
-
Seoul National University HospitalCompletedRecurrent or Metastatic Nasopharyngeal CarcinomKorea, Republic of
-
Samyang Biopharmaceuticals CorporationUnknownMetastatic Adenocarcinoma of the Pancreas | Recurrent Adenocarcinoma of the PancreasKorea, Republic of
-
Regeneron PharmaceuticalsSanofiCompletedRecurrent Squamous Cell Carcinoma of Head | Recurrent Squamous Cell Carcinoma of Neck | Metastatic Squamous Cell Carcinoma of Head | Metastatic Squamous Cell Carcinoma NeckKorea, Republic of, United Kingdom
-
Yonsei UniversityUnknownInoperable or Recurrent or Metastatic Esophageal Squamous CarcinomaKorea, Republic of
-
National Cancer Center, KoreaCompletedRecurrent Small Hepatocellular Carcinoma | Residual Small Hepatocellular CarcinomaKorea, Republic of
-
Samsung Medical CenterCompletedAdvanced or Recurrent Esophageal Squamous Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalRF medicalRecruitingChronic Liver Disease and Cirrhosis | Recurrent Hepatocellular CancerKorea, Republic of
-
Samsung Medical CenterUnknownFirst Line Chemotherapy | Capecitabine Plus Cisplatin Versus Capecitabine Plus Paclitaxel | Advanced or Recurrent Esophageal Squamous Cell CarcinomaKorea, Republic of
-
Yonsei UniversityRecruitingRecurrent Ovarian CancerKorea, Republic of
-
Yonsei UniversityRecruitingRecurrent Epithelial Ovarian CancerKorea, Republic of
-
Pusan National University Yangsan HospitalRecruitingUrothelial Carcinoma | Neoadjuvant Chemotherapy | Muscle Invasive Bladder CancerKorea, Republic of
-
Yonsei UniversitySamsung Medical Center; AstraZeneca; Seoul National University Hospital; Korean... and other collaboratorsRecruitingPlatinum-resistant Recurrent Ovarian CancerKorea, Republic of
-
Asan Medical CenterKorean Cancer Study GroupUnknownTransitional Cell Carcinoma | Bladder Cancer | Ureter CancerKorea, Republic of
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
Yonsei UniversityEnrolling by invitationPlatinum-sensitive Recurrent BRCA Wild Type Ovarian CancerKorea, Republic of
-
Seoul National University HospitalCompletedRecurrent ACC, metastaticACC, Unreaectable ACCKorea, Republic of
-
Yonsei UniversityTakedaRecruitingPlatinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP InhibitorKorea, Republic of
-
Seoul National University HospitalBoryung Pharmaceutical Co., LtdActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Recurrent Ovarian Carcinoma | Chemotherapy-induced Peripheral Neuropathy | Primary Peritoneal CarcinomaKorea, Republic of
-
Yonsei UniversityUnknownRecurrent or Metastatic Squamous Cell Carcinoma of Head and NeckKorea, Republic of
-
Seoul National University HospitalRF medicalActive, not recruitingHepatocellular Carcinoma | Local Recurrence of Malignant Tumor of LiverKorea, Republic of
-
Samsung Medical CenterCompletedMetastatic Carcinoma | Recurrent Esophageal Squamous Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalUnknownProstate Cancer Recurrent | Stage II Prostate Carcinoma | Stage III Prostate CarcinomaKorea, Republic of
-
Janssen Research & Development, LLCRecruitingRecurrent/Metastatic Head and Neck Squamous Cell CarcinomaKorea, Republic of, Taiwan, Malaysia, United States
-
Millennium Pharmaceuticals, Inc.TerminatedMetastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Recurrent Gastric Adenocarcinoma | Recurrent Gastroesophageal Junction Adenocarcinoma | Advanced Gastrointestinal Carcinoma | Recurrent Gastrointestinal CarcinomaTaiwan, Korea, Republic of, Japan
-
Yonsei UniversityUnknownHead Neck Cancer Squamous Cell Recurrent | Head Neck Cancer Squamous Cell MetastaticKorea, Republic of
-
Yonsei UniversityCompletedHepatocellular CarcinomaKorea, Republic of
-
Yonsei UniversityCompletedHead Neck Cancer Squamous Cell Recurrent | Head Neck Cancer Squamous Cell MetastaticKorea, Republic of
-
Seoul National University HospitalCompletedHepatocellular Carcinoma | Hepatic FibrosisKorea, Republic of
-
Seoul National University HospitalMACROGENUnknownNon Small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer RecurrentKorea, Republic of
-
Chonnam National University HospitalRoche Pharma AGCompletedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentKorea, Republic of
-
Se-Hoon LeeTerminatedAZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer (SUKSES-N5)SCLC, RecurrentKorea, Republic of
-
Korean Association of Endocrine SurgeonsUnknownRecurrence | Thyroid CancerKorea, Republic of
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Urothelial Carcinoma | Urothelial NeoplasmsAustralia, United States, Canada, Chile, France, Israel, Italy, Korea, Republic of, Netherlands, Spain, Taiwan, United Kingdom
-
JI-YOUN HANNational Cancer Center, KoreaCompletedSmall Cell Lung Cancer | Small Cell Lung Cancer RecurrentKorea, Republic of
-
National Cancer Center, KoreaRoche Korea co.,Ltd.RecruitingSequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLC (Atezolizumab)Small Cell Lung Cancer RecurrentKorea, Republic of
-
Seoul National University HospitalCompletedCarcinoma, Hepatocellular | Chronic Hepatitis BKorea, Republic of
-
Genentech, Inc.TerminatedUrothelial CarcinomaKorea, Republic of, United States, Canada, United Kingdom, Belgium
-
Merck Sharp & Dohme LLCActive, not recruitingUrothelial CarcinomaAustralia, United States, Chile, Denmark, Israel, Korea, Republic of, Spain
-
Novartis PharmaceuticalsTerminatedRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaFrance, Taiwan, United States, Australia, Canada, Hong Kong, Singapore, Korea, Republic of, Netherlands
-
Hoffmann-La RocheCompletedSmall Cell Lung Carcinoma | Hepatocellular Carcinoma | Carcinoma, Non-Small Cell Lung | Urothelial Carcinoma | Triple Negative Breast CarcinomaKorea, Republic of
-
Kinnate BiopharmaActive, not recruitingIntrahepatic Cholangiocarcinoma | Urothelial Carcinoma | Solid Tumor, AdultUnited States, Korea, Republic of, Taiwan, China, Denmark, Spain
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar TherapeuticsRecruitingLocally Advanced or Metastatic Urothelial CarcinomaKorea, Republic of, United States, Taiwan, Australia, United Kingdom, France, Greece, Italy, Belgium, Spain, Canada, Denmark, Germany